Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(16/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(16/week)
News
United States
(629/week)
Manufacturing
(446/week)
Energy
(349/week)
Technology
(488/week)
Other Manufacturing
(372/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Enzalutamide
Apr 25, 2019
ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019
Apr 17, 2019
ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting
Apr 12, 2019
ESSA Pharma Grants Stock Options
Mar 28, 2019
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
Mar 18, 2019
ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference
Mar 14, 2019
ESSA Pharma to Attend the 31st Annual ROTH Conference
Mar 13, 2019
Large Prospective Trial Validates Detection of AR-V7 Biomarker Using Epic Sciences' Platform to Predict Treatment Outcomes for Patients with Advanced Prostate Cancer
Feb 11, 2019
ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
Feb 11, 2019
Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer
Jan 14, 2019
Leap Therapeutics Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer
Dec 20, 2018
Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer
Nov 06, 2018
New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers
Oct 29, 2018
Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castrate Resistant Prostate Cancer Effective December 10
Oct 22, 2018
Genomic Health Announces Multiple Studies Reinforcing Value of Oncotype DX® Tests in Guiding Treatment for Breast and Prostate Cancer Patients
Oct 22, 2018
ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors
Sep 24, 2018
Astellas Receives Positive CHMP Opinion for XTANDI® (enzalutamide) for Adult Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer
Aug 22, 2018
Predicine and Kintor Pharma to Present ctDNA & ctRNA Biomarker Data for PhI/II Clinical Trial in mCRPC at ESMO 2018
Aug 22, 2018
Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials of Enzalutamide in Patients with Hormone-Sensitive Prostate Cancer
Jul 13, 2018
U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
Jun 28, 2018
Blood Test Predicts Treatment Response and Survival for Patients with Metastatic Prostate Cancer
‹‹
Page 3
››
Latest News
May 6, 2024
Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site
May 6, 2024
Ambri Agrees to Terms of Proposed Sale with Lender Consortium
May 6, 2024
Atos se fixe jusqu'au 31 mai pour trouver son plan de sauvetage financier
May 6, 2024
Atos a reçu quatre propositions financières pour son sauvetage, se donne jusqu'au 31 mai pour choisir
May 6, 2024
Atos a reçu quatre propositions financières pour son sauvetage, se donne jusqu'au 31 mai pour choisir (...
May 6, 2024
Philippines, US fire at 'invasion' force in South China Sea war games
May 6, 2024
Qantas to pay $66 million fine after 'ghost flights' scandal
May 5, 2024
California American Water celebrates Drinking Water Week and 50th anniversary of Safe Drinking Water Act
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events